Catalyst Funds Management Pty »

Maxcyte shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2024-12-31 $74k 18k 4.16

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Maxcyte

BlackRock
Cadian Capital Management
Mirabella Financial Services
Vanguard Group
Vitruvian Partners
Mudita Advisors
AXA Investment Managers
Geode Capital Management
State Street Corporation
Kennedy Capital Management
Dimensional Fund Advisors
Willis Investment Counsel
Citadel Advisors
Northern Trust
Renaissance Technologies

View all funds holding Maxcyte